Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease | BMC Gastroenterology | Full Text
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
חישוב FIB4 | Maviret
NAFLD fibrosis score + FIB4 | Infamedic
Why are non-invasive risk scores such as FIB-4 used in clinical practice? | Liver Fellow Network
Impact of Pre-Screening with Fibrosis-4 Index on a Referral Pathway for Patients with Suspected NAFLD
FIB-4 Index - Fatty Liver Foundation
FIB-4 Calculator | Liver Fibrosis Score Calculator
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink
Non-Alcoholic Fatty Liver Diagnosis - Viral Hepatitis and Liver Disease
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
IJMS | Free Full-Text | Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting - Vieira Barbosa - 2021 - Hepatology Communications - Wiley Online Library
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
Identifying Patients With Advanced Fibrosis: Noninvasive Tests (NITs)
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease - Eda Kaya, Yusuf Yilmaz, 2022
NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome
